Author/Authors :
Seyyedi, Reza Lung Transplantation Research Center - Department of Cardiology - National Research Institute of Tuberculosis and Lung Diseases - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Sadeghipour, Parham Cardiovascular Intervention Research Center - Rajaie Cardiovascular Medical and Research Center - Iran University of Medical Sciences, Tehran, Iran , Sadr, Makan Virology Research Center - National Research Institute of Tuberculosis and Lung Diseases - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Shafe, Omid Cardiovascular Intervention Research Center - Rajaie Cardiovascular Medical and Research Center - Iran University of Medical Sciences, Tehran, Iran , Moosavi, Jamal Cardiovascular Intervention Research Center - Rajaie Cardiovascular Medical and Research Center - Iran University of Medical Sciences, Tehran, Iran , Aloosh, Oldooz Lung Transplantation Research Center - Department of Cardiology - National Research Institute of Tuberculosis and Lung Diseases - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Abedini, Atefeh Lung Transplantation Research Center - Department of Cardiology - National Research Institute of Tuberculosis and Lung Diseases - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Sharif-Kashani, Babak Lung Transplantation Research Center - Department of Cardiology - National Research Institute of Tuberculosis and Lung Diseases - Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract :
Background: Massive hemoptysis is a potentially life threatening medical
condition and one major problem for both patients and physicians. Choosing
the appropriate treatment for the patients is crucial in order to decrease the
complications and increase the success rate. Hence, in this study the outcomes
and complications of bronchial angioembolization (BAE) were determined in
patients with massive hemoptysis.
Materials and Methods: In this prospective cohort, 189 consecutive patients
with moderate and severe hemoptysis who had referred to two large
cardiovascular centers were enrolled. The Chest X Ray, CT Scan, Fiberoptic
Bronchoscopy, Selective and Nonselective Bronchial Angiography were
performed in patients. The outcomes with 20-month follow-up were compared.
Results: The immediate success rate was 97.3%. In 79.7% there were no
complications. Temporary chest pain, subintimal dissection, temporary
dysphagia, and pancreatitis were seen in 12.3, 2.4, 5.1, and 0.5%, respectively,
without any major complication. The in-hospital mortality rate was 1.1% and
mortality during 20-month follow-up was 9.6%, and recurrence rate was 28.3%
on total.
Conclusion: Our case series showed that BAE is a safe and effective method in
treating patients with hemoptysis. Compared to surgery, the procedure is faster
and less invasive and might be used both as first line or bridging therapy.
Importantly, no major complications have been detected
